Mobile Medical Application Market Size, Share and Trends Analysis Report, Forecast 2022-2030

The Global Mobile Medical Application Market is expected to grow at a CAGR of around 27.8% from 2022 to 2030 and reach the market value of over US$ 51.5 Billion by 2030.

Mobile medical applications or mobile medical apps are typically application software designed to run on mobile devices like smartphones, tablets, or laptops. Some of the common examples of medical mobile applications include neurological and mental health apps, sleep apnea monitoring apps, fitness apps, medical reference apps, wellness apps, nutrition apps, personal health record apps, chronic disease management apps, diagnostic apps, remote monitoring apps, reminder, and alert apps, consultation and compliance apps, fertility apps, and pregnancy apps. Additionally, some of the major therapeutic areas that use mobile medical applications include cardiovascular, diabetes, respiratory, and neurology.

Download Sample Pages Of This Report@ https://www.acumenresearchandconsulting.com/request-sample/2445

The global mobile medical application market is segmented on the basis of category, subscription, platform, application, end-user, and geography. Based on category, the market is divided into care management apps, medical monitoring apps, health and wellness apps, women health apps, medication management apps, and others. On the basis of subscription, market segments include free subscription and fee-based subscription. Additionally, mobile medical applications have applications across clinical or assistance in the diagnosis, remote monitoring, reminders, and alerts, references. Moreover, the end-user includes residents and physicians.

In 2019, North America held the major share (%) in the mobile medical application market along with its major economies US and Canada. The well-established healthcare infrastructure coupled with the presence of major global players in the region is primarily accelerating the regional market value. The escalating obese population, increasing mobile screen spending time due to increasing usage of borderline-addicting games, video apps, and social media apps are further supporting the demand and usage of health applications in the residents.

View Table Of Content Of This Report@ https://www.acumenresearchandconsulting.com/mobile-medical-application-market

Asia Pacific is anticipated to exhibit the fastest growth over the forecast timeframe from 2020 to 2027. The major developing economies of the region including China and India are the prominent contributors to the regional market growth. The rapid technological advancement along with the increasing investment in the healthcare sector is bolstering the regional market value.

Some of the leading competitors are AT&T, Inc. Athena health, Inc., Biotelemetry, Inc., Cerner Corporation, Cisco Systems, Inc., Johnson & Johnson, Lifewatch Ag, Medtronic PLC, Omron Corporation, Philips Healthcare, and others. Mobile Medical Application companies have announced mergers and acquisitions, partnerships & collaborations, and new product development to uplift their position in the mobile medical application industry. Major players are also moving into new regions with advanced technologies for gaining a competitive advantage.

Browse Upcoming Market Research Reports@ https://www.acumenresearchandconsulting.com/forthcoming-reports

Some of the key observations regarding the mobile medical application industry include:

• Epocrates has reached an estimated 525,000 users worldwide by 2006 including 200,000 doctors in the United States. The mobile medical reference app is owned by a US-based organization Athena health, which provides clinical reference information on drugs, diseases, diagnostics, and patient management. Athenahealth subsidiary, Epocrates has pulled its Bugs + Drugs app from the app store which was launched in 2013, shortly after Athena health acquired Epocrates.

• Medscape app provides the largest network for physicians and medical students and shares challenging patient cases, discuss clinical topics. Additionally, crowd source medical answers from fellow users and provide direct access to experts from leading institutions like Columbia Doctors. Medscape has carried out research in collaboration with the 23andMe in 2018. The research has included 1,000 primary care physicians (PCPs) in order to measure their attitudes toward direct-to-consumer (DTC) genetic health testing. The report also found 80 percent of PCPs are open or likely to recommend DTC genetic testing for health if asked about it by their patients.

• Nursing Central provides detailed information on diseases, tests, and procedures and encompasses a database of 5000 drugs or refers to more than 65,000 dictionary terms. It includes award-winning functionality along with twelve months of web and mobile access at the price of US$ 179.95 with a year subscription.

Inquiry Before Buying@ https://www.acumenresearchandconsulting.com/inquiry-before-buying/2445

Buy This Premium Research Report - https://www.acumenresearchandconsulting.com/buy-now/0/2445

201, Vaidehi-Saaket, Baner - Pashan Link Rd, Pashan, Pune, Maharashtra 411021

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

This release was published on openPR.